TRIAZINE DERIVATIVES FOR USE IN THE TREATMENT OF MALARIA
    3.
    发明授权
    TRIAZINE DERIVATIVES FOR USE IN THE TREATMENT OF MALARIA 有权
    TRIAZINDERIVATE ZUR BEHANDLUNG VON MALARIA

    公开(公告)号:EP2464353B1

    公开(公告)日:2017-03-29

    申请号:EP10748152.5

    申请日:2010-08-06

    申请人: CSIR

    摘要: The invention provides compounds of formula (I), in which R1 and R2 are independently selected from H, alkyl, aryl and heteroaryl, or R1 and R2 together form a C5-C7 ring, R3-R7 are independently selected from H, halogen, alkyl and alkoxy, X is (CH2)n in which n is 0-5, Y is selected from CH2, NR8, O or S in which R8 is H or alkyl, salts thereof and stereoisomers thereof, for the prophylaxis or treatment of malaria.

    摘要翻译: 本发明提供式(I)化合物,其中R 1和R 2独立地选自H,烷基,芳基和杂芳基,或者R 1和R 2一起形成C 5 -C 7环,R 3 -R 7独立地选自H,卤素, 烷基和烷氧基,X是(CH 2)n,其中n是0-5,Y选自其中R 8是H或烷基的CH 2,NR 8,O或S,其盐和其立体异构体,用于预防或治疗疟疾 。